These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3499953)

  • 21. Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats.
    Jung S; Toyka KV; Hartung HP
    Neurosci Lett; 1995 Nov; 200(3):167-70. PubMed ID: 9064603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
    Lonigro A; Devaux JJ
    Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to P2 and P1 myelin antigens in experimental allergic neuritis and allergic encephalomyelitis.
    Zweiman B; Moskovitz AR; Rostami A; Lisak RP; Pleasure DE; Brown MJ
    J Neuroimmunol; 1982 Jun; 2(3-4):331-6. PubMed ID: 6177713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
    De La Hoz CL; Castro FR; Santos LM; Langone F
    Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes.
    Hodgkinson SJ; Westland KW; Pollard JD
    J Neurol Sci; 1994 May; 123(1-2):162-72. PubMed ID: 8064309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells.
    Yu S; Zhu Y; Chen Z; Alheim M; Ljungberg A; Zhu J
    J Neurosci Res; 2002 Mar; 67(6):823-8. PubMed ID: 11891797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses in experimental allergic neuritis.
    Hughes RA; Kadlubowski M; Gray IA; Leibowitz S
    J Neurol Neurosurg Psychiatry; 1981 Jul; 44(7):565-9. PubMed ID: 6974764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-nerve barrier studies in experimental allergic neuritis.
    Hahn AF; Feasby TE; Gilbert JJ
    Acta Neuropathol; 1985; 68(2):101-9. PubMed ID: 3878061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive transfer of experimental allergic neuritis in the immune suppressed host.
    Hahn AF; Feasby TE; Lovgren D; Wilkie L
    Acta Neuropathol; 1993; 86(6):596-601. PubMed ID: 7508670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of experimental allergic neuritis with prednisolone.
    Feasby TE; Gilbert JJ; Hahn AF; Lovgren DS
    Can J Neurol Sci; 1987 Feb; 14(1):46-9. PubMed ID: 3493057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum.
    Harvey GK; Pollard JD
    J Neuroimmunol; 1992 Dec; 41(2):159-66. PubMed ID: 1334966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats.
    Moriguchi K; Miyamoto K; Kusunoki S
    J Neuroimmunol; 2017 Apr; 305():72-74. PubMed ID: 28284349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis.
    Strigård K; Larsson P; Holmdahl R; Klareskog L; Olsson T
    J Neuroimmunol; 1989 Jun; 23(1):11-8. PubMed ID: 2470777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of experimental allergic neuritis serum on normal rat peripheral nerve.
    Rosen JL; Brown MJ; Rostami A
    Pathobiology; 1990; 58(2):95-8. PubMed ID: 1694436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunoglobulin ameliorates rat experimental autoimmune neuritis.
    Gabriel CM; Gregson NA; Redford EJ; Davies M; Smith KJ; Hughes RA
    Brain; 1997 Sep; 120 ( Pt 9)():1533-40. PubMed ID: 9313637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.